Omeprazol Sandoz (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Sandoz, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to treat acid‑related disorders such as gastro‑esophageal reflux disease, peptic ulcer disease and Zollinger‑Ellison syndrome.

GNH USA supplies Omeprazol Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Sandoz, a proton pump inhibitor, acts on the gastric acid secretion pathway to manage several acid‑related conditions. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and regurgitation by decreasing stomach acid. - Peptic ulcer disease: promotes healing of gastric and duodenal ulcers through acid suppression. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion caused by gastrin‑producing tumors.

Adverse reactions may occur with omeprazole therapy.

Common Side Effects: - Headache: mild to moderate pain often transient. - Diarrhea: loose stools that may resolve with continued use. - Abdominal pain: discomfort or cramping in the stomach area. - Nausea: feeling of sickness or urge to vomit.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): difficulty breathing, swelling, rash. - Clostridioides difficile infection: severe diarrhea and colitis. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat, seizures.

Before initiating therapy, consider the following precautions. - Assess renal function: adjust use in patients with severe impairment. - Review concomitant medications: potential reduced efficacy of clopidogrel. - Use with caution in elderly: higher incidence of adverse events. - Avoid long‑term use without medical supervision: risk of nutrient deficiencies such as vitamin B12. - Store at room temperature: keep in the original container, protect from moisture and light.

Omeprazole may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Clarithromycin: increased risk of serious cardiac events. - Ketoconazole: reduced absorption and effectiveness. - Atazanavir: markedly decreased antiviral activity.

Moderate Interactions (Monitor Closely): - Warfarin: possible enhancement of anticoagulant effect. - Digoxin: increased serum concentrations. - Methotrexate: reduced renal clearance leading to toxicity.